Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.2 USD | +3.11% | +2.59% | +43.19% |
01:31pm | Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target | MT |
Apr. 03 | XOMA Corporation completed the acquisition of Kinnate Biopharma Inc.. | CI |
- Stock Market
- Equities
- XOMA Stock
- News XOMA Corporation
- Transcripts